These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1304 related items for PubMed ID: 16696680

  • 1. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
    Hütt P, Shchepetova J, Lõivukene K, Kullisaar T, Mikelsaar M.
    J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680
    [Abstract] [Full Text] [Related]

  • 2. Characterization of oral lactobacilli as potential probiotics for oral health.
    Kõll P, Mändar R, Marcotte H, Leibur E, Mikelsaar M, Hammarström L.
    Oral Microbiol Immunol; 2008 Apr; 23(2):139-47. PubMed ID: 18279182
    [Abstract] [Full Text] [Related]

  • 3. [Antagonistic activity of Lactobacillus bacteria strains against anaerobic gastrointestinal tract pathogens (Helicobacter pylori, Campylobacter coli, Campylobacter jejuni, Clostridium difficile)].
    Strus M, Pakosz K, Gościniak H, Przondo-Mordarska A, Rozynek E, Pituch H, Meisel-Mikołajczyk F, Heczko PB.
    Med Dosw Mikrobiol; 2001 Apr; 53(2):133-42. PubMed ID: 11757422
    [Abstract] [Full Text] [Related]

  • 4. Subtractive screening for probiotic properties of lactobacillus species from the human gastrointestinal tract in the search for new probiotics.
    Delgado S, O'Sullivan E, Fitzgerald G, Mayo B.
    J Food Sci; 2007 Oct; 72(8):M310-5. PubMed ID: 17995611
    [Abstract] [Full Text] [Related]

  • 5. Assessment of cell surface properties and adhesion potential of selected probiotic strains.
    Xu H, Jeong HS, Lee HY, Ahn J.
    Lett Appl Microbiol; 2009 Oct; 49(4):434-42. PubMed ID: 19725886
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains.
    Schoster A, Kokotovic B, Permin A, Pedersen PD, Dal Bello F, Guardabassi L.
    Anaerobe; 2013 Apr; 20():36-41. PubMed ID: 23471038
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients.
    Timmerman HM, Niers LE, Ridwan BU, Koning CJ, Mulder L, Akkermans LM, Rombouts FM, Rijkers GT.
    Clin Nutr; 2007 Aug; 26(4):450-9. PubMed ID: 17544549
    [Abstract] [Full Text] [Related]

  • 11. Lactic acid bacteria as probiotics.
    Ljungh A, Wadström T.
    Curr Issues Intest Microbiol; 2006 Sep; 7(2):73-89. PubMed ID: 16875422
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prebiotic preferences of human lactobacilli strains in co-culture with bifidobacteria and antimicrobial activity against Clostridium difficile.
    Ambalam P, Kondepudi KK, Balusupati P, Nilsson I, Wadström T, Ljungh Å.
    J Appl Microbiol; 2015 Dec; 119(6):1672-82. PubMed ID: 26381324
    [Abstract] [Full Text] [Related]

  • 14. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains.
    Mogna L, Del Piano M, Deidda F, Nicola S, Soattini L, Debiaggi R, Sforza F, Strozzi G, Mogna G.
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S29-32. PubMed ID: 22955353
    [Abstract] [Full Text] [Related]

  • 15. Sugar fermentation in probiotic bacteria--an in vitro study.
    Hedberg M, Hasslöf P, Sjöström I, Twetman S, Stecksén-Blicks C.
    Oral Microbiol Immunol; 2008 Dec; 23(6):482-5. PubMed ID: 18954354
    [Abstract] [Full Text] [Related]

  • 16. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.
    Servin AL.
    FEMS Microbiol Rev; 2004 Oct; 28(4):405-40. PubMed ID: 15374659
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stationary-phase acid and heat treatments for improvement of the viability of probiotic lactobacilli and bifidobacteria.
    Saarela M, Rantala M, Hallamaa K, Nohynek L, Virkajärvi I, Mättö J.
    J Appl Microbiol; 2004 Oct; 96(6):1205-14. PubMed ID: 15139911
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production.
    Candela M, Perna F, Carnevali P, Vitali B, Ciati R, Gionchetti P, Rizzello F, Campieri M, Brigidi P.
    Int J Food Microbiol; 2008 Jul 31; 125(3):286-92. PubMed ID: 18524406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.